查看购物车
  • Traditional Chinese
  • English
  • Japanese
拉丁美洲化学发光免疫分析市场规模和预测、区域份额、趋势和成长机会分析报告范围：按应用、最终用户和国家分类
市场调查报告书
商品编码
1571390

拉丁美洲化学发光免疫分析市场规模和预测、区域份额、趋势和成长机会分析报告范围：按应用、最终用户和国家分类

Latin America Chemiluminescence Immunoassay Market Size and Forecast, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application, End User, and Country
出版日期: | 出版商: The Insight Partners | 英文 88 Pages | 订单完成后即时交付

价格

拉丁美洲化学发光免疫分析市场规模预计将从2023年的4.9767亿美元成长到2031年的9.5512亿美元；预计 2023-2031 年复合年增长率为 8.6%。

腿部加压包扎旨在控制和缓解淋巴水肿症状。这些包裹物透过对腿部受影响的区域施加控制压力来帮助淋巴流动并减少肿胀。与传统的压力袜相比，压力袜是可调节的，使其成为难以穿着压力袜或水肿程度波动的个人的理想选择。可调式压缩包布的成本要低得多，并且在实现溃疡癒合方面更有效。因此，在治疗腿部静脉溃疡时，可调节加压包扎是非弹性绷带的强大、自用且经济有效的替代方案。静脉疾病发生率的增加和导致淋巴水肿的癌症发生率的增加是导致拉丁美洲化学发光免疫分析市场扩大的重要因素。然而，替代疗法的可用性阻碍了拉丁美洲化学发光免疫分析市场的成长，因为淋巴水肿、慢性静脉功能不全、週边水肿、静脉瘀血性溃疡和静脉曲张等疾病也可以透过药物和外科手术（尤其是微创手术）进行治疗。其他用于治疗上述病症的治疗程序包括泡沫硬化疗法、雷射治疗、门诊静脉切除术以及使用射频或雷射能量的导管辅助程序。间歇性气动加压装置等技术也可用于防止腿部深层静脉血栓。它采用一种装置来模仿自然肌肉收缩，帮助静脉回流。因此，替代疗法的可用性，例如用于治疗上述病症的压缩衣、设备和疗法，阻碍了拉丁美洲化学发光免疫分析市场的成长。

基于应用程式的见解

根据应用，拉丁美洲化学发光免疫分析市场分为肿瘤学、生育力、内分泌学、心臟病学、传染病、糖尿病等。 2023 年，肿瘤学领域占据了拉丁美洲化学发光免疫分析市场最大份额。 根据《刺胳针》报道，截至2023 年，拉丁美洲和加勒比海(LAC) 地区每年记录约150 万新癌症病例和约70 万癌症相关死亡。 ，每10 万人中95 人。据巴西癌症杂誌Revista Brasileira de Cancerologia 称，2023 年巴西报告了近704,000 例新癌症病例。 A (CgA) 水平。此检测可作为辅助检测嗜铬细胞瘤和神经内分泌肿瘤（如类癌等）患者。

此外，预计2023 年至2031 年生育领域的复合年增长率最高。以及12,778 例分娩和分娩。根据拉丁美洲和加勒比海经济委员会的数据，拉丁美洲的总生育率（TFR）在 2015 年低于更替水平，预计 2022 年每名妇女的活产数为 1.85，进一步预测将降至 1.68到2100 年。平均生育年龄也有增加。 Biopanda催乳素化学发光免疫分析检测试剂盒提供了一种定量测定人类血清中催乳素的方法。化学发光免疫分析法由于相关性高、实用性增强等因素，已取代放射免疫分析法成为目前血清孕酮测定的标准。因此，上述因素支持了拉丁美洲化学发光免疫分析市场的成长。

基于最终用户的见解

根据最终用户，拉丁美洲化学发光免疫分析市场分为医院、血库、临床实验室、製药和生物技术公司等。 2023 年，医院细分市场占据拉丁美洲化学发光免疫分析市场最大份额，预计临床实验室细分市场在 2023-2031 年期间将实现最高的复合年增长率。免疫诊断测试在医院的不同部门进行，包括临床微生物实验室、病理实验室、血清学实验室、组织病理学和血液学科室、临床生化实验室和医院病房。一些免疫诊断仪器可以快速提供结果，而在进行复杂测试时，样本会被送到专门的实验室。医院环境中对即时 (POC) 免疫分析测试产品的需求不断增长，有利于 CLIA 市场。目前，CLIA检测主要用于检测肿瘤标记以及诊断传染病、内分泌失调、糖尿病等。透过在一个自动化系统中实现如此多样化的应用，CLIA 系统在医院中具有重要的适用性。

然而，按照国内或国际监管要求建立的诊断实验室使用基于 CLIA 的试剂盒和仪器为医院、诊所、家庭护理机构等提供诊断服务。的实践是支持拉丁美洲化学发光免疫分析诊断实验室市场成长的因素。

全球癌症观测站、经合组织和国家生物技术资讯中心是准备拉丁美洲化学发光免疫分析市场报告时参考的主要和次要来源。

目录

第 1 章：简介

第 2 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 3 章：拉丁美洲化学发光免疫分析 (CLIA) 市场格局

  • 市场概况
  • PEST分析

第 4 章：拉丁美洲化学发光免疫分析 (CLIA) 市场 - 主要市场动态

  • 拉丁美洲化学发光免疫分析市场 - 主要市场动态
  • 市场驱动因素：
    • 传染病发生率上升
    • 越来越多地使用现场诊断
  • 市场限制
    • 报销不足
  • 市场机会
    • 更加重视研发
  • 未来趋势
    • 技术进步
  • 驱动因素和限制的影响：

第 5 章：拉丁美洲化学发光免疫分析 (CLIA) 市场分析

  • 化学发光免疫分析（CLIA）市场
    • 概述
    • 化学发光免疫分析 (CLIA)：化学发光免疫分析 (CLIA) 市场 - 收入和 2031 年预测

第 6 章：拉丁美洲化学发光免疫分析 (CLIA) 市场分析 - 按应用

  • 肿瘤学
  • 生育能力
  • 内分泌科
  • 心臟病学
  • 传染病
  • 糖尿病
  • 其他的

第 7 章：拉丁美洲化学发光免疫分析 (CLIA) 市场分析 - 按最终用户

  • 医院
  • 血库
  • 临床实验室
  • 製药和生物技术公司
  • 其他的

第 8 章：拉丁美洲化学发光免疫分析 (CLIA) 市场 - 区域分析

  • 概述
  • 拉丁美洲
    • 拉丁美洲化学发光免疫分析 (CLIA) 市场概况
    • 拉丁美洲：拉丁美洲化学发光免疫分析 (CLIA) - 收入和 2031 年预测
      • 拉丁美洲：拉丁美洲化学发光免疫分析 (CLIA) 市场 - 收入和预测分析 - 按应用
      • 拉丁美洲：拉丁美洲化学发光免疫分析 (CLIA) 市场 - 收入和预测分析 - 按最终用户
      • 巴西：化学发光免疫分析 (CLIA) 市场 - 收入和 2031 年预测
      • 阿根廷：化学发光免疫分析 (CLIA) 市场 - 收入和 2031 年预测
      • 智利：化学发光免疫分析 (CLIA) 市场 - 收入和 2031 年预测
      • 墨西哥：化学发光免疫分析 (CLIA) 市场 - 收入和 2031 年预测
      • 拉丁美洲其他地区：化学发光免疫分析 (CLIA) 市场 - 收入和 2031 年预测

第 9 章：公司简介

  • Sysmex Corp
  • Shenzhen Mindray Bio-Medical Electronics Co Ltd
  • Bio-Rad Laboratories Inc
  • Merck KGaA
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Hoffmann-La Roche Ltd
  • DiaSorin SpA
  • Siemens Healthineers AG
  • Getein Biotech Inc.

第 10 章：附录

Product Code: TIPRE00039333

The Latin America chemiluminescence immunoassay market size is expected to grow from US$ 497.67 million in 2023 and is projected to reach US$ 955.12 million by 2031; it is expected to register a CAGR of 8.6% during 2023-2031.

Compression wraps for legs are designed to manage and alleviate the symptoms of lymphedema. These wraps help with the flow of lymph fluids and decrease swelling by applying controlled pressure to the affected areas of the leg. Compared to traditional compression stockings, compression wraps are adjustable, making them an ideal choice for individuals having difficulty putting on stockings or are experiencing fluctuating levels of edema. Adjustable compression wraps are considerably less expensive and more effective in achieving ulcer healing. Therefore, adjustable compression wraps are a powerful, self-applicable, and cost-effective alternative to inelastic bandages in treating venous leg ulcers. The increasing occurrence of venous conditions and the growing incidence of cancer leading to lymphedema are noteworthy factors contributing to the expansion of the Latin America chemiluminescence immunoassay market size. However, the availability of alternate treatments hinders the Latin America chemiluminescence immunoassay market growth as conditions such as lymphedema, chronic venous insufficiency, peripheral edema, venous stasis ulcers, and varicose veins can also be treated via medication and surgical procedures, especially minimally invasive procedures. Other treatment procedures used to treat the abovementioned conditions include foam sclerotherapy, laser treatment, ambulatory phlebectomy, and catheter-assisted procedures that use radiofrequency or laser energy. Techniques such as intermittent pneumatic compression devices are also used to prevent blood clots in the deep veins of the legs. It employs a device to mimic natural muscle contractions, aiding in venous return. Thus, the availability of alternative treatments, such as compression garments, devices, and therapies for the treatment of the abovementioned conditions, hampers the growth of the Latin America chemiluminescence immunoassay market.

Application-Based Insights

Based on application, the Latin America chemiluminescence immunoassay market is segmented into oncology, fertility, endocrinology, cardiology, infectious diseases, diabetes, and others. The oncology segment held the largest Latin America chemiluminescence immunoassay market share in 2023. According to the Lancet, ~1.5 million new cancer cases and ~700,000 cancer-related deaths are annually recorded in Latin America and the Caribbean (LAC) region as of 2023. According to the World Health Organization, in Brazil, cancer is ranked as the second leading cause of death, resulting in 227,920 deaths in 2018. It also reports that the age-adjusted death rate due to cancer is 111 per 100,000 for men and 95 per 100,000 for women. According to the Revista Brasileira de Cancerologia, nearly 704,000 new cancer cases were reported in Brazil in 2023. For instance, the EDI Human Chromogranin A CLIA Kit is indicated for the quantitative detection of human chromogranin A (CgA) levels in serum using the ECL100 or ECL25 immunoassay analyzer. This test may be used as an aid to detect patients with pheochromocytoma and neuroendocrine tumors (such as carcinoids, etc.).

In addition, the Fertility segment is expected to register the highest CAGR from 2023 to 2031. According to the National Institutes of Health (NIH), ~188 centers in 16 countries reported 87,732 females had their first menstrual cycles in 2020, and 12,778 childbirths and 14,405 live births were recorded in Latin America. According to the Comision Economica para America Latina y el Caribe, the total fertility rate (TFR) of Latin America, which fell below replacement level in 2015, was estimated at 1.85 live births per woman in 2022, with a further projection to drop to 1.68 by 2100. There has also been an increase in the average age of fertility. The Biopanda Prolactin chemiluminescence immunoassay test kit provides a means for the quantitative determination of prolactin in human serum. Chemiluminescent immunoassay has replaced radioimmunoassay in the measurement of serum progesterone as a current standard owing to factors such as high correlation and increased practicality. Thus, the factors mentioned above support Latin America chemiluminescence immunoassay market growth.

End User-Based Insights

Based on end user, the Latin America chemiluminescence immunoassay market is segmented into hospitals, blood banks, clinical laboratories, pharmaceutical & biotech companies, and others. The hospitals segment held the largest Latin America chemiluminescence immunoassay market share in 2023 and clinical laboratories segment is expected to register the highest CAGR in the market during 2023-2031. Immunodiagnostics tests are performed in different hospital departments, including clinical microbiology labs, pathological labs, serological labs, histopathology and hematology sections, clinical biochemistry labs, and hospital wards. Some A few immunodiagnostic instruments provide quick results, while samples are sent to specialized laboratories in the case of complex tests. The rising demand for point-of-care (POC) immunoassay testing products in hospital settings benefits the CLIA market. At present, CLIA tests are employed to detect tumor markers and diagnose infectious diseases, endocrine disorders, diabetes, and so on. With such varied applications in one automated system, CLIA systems find significant applicability in hospitals.

However, Diagnostic laboratories, built in adherence to domestic or international regulatory requirements, use CLIA-based kits and instruments for providing diagnostics services to hospitals, clinics, at-home care setups, etc. The surging prevalence of chronic and infectious diseases in Latin America, and the practice of outsourcing immunodiagnostics procedures are the factors supporting the Latin America chemiluminescence immunoassay market growth in the diagnostic laboratories segment.

The Global Cancer Observatory, OECD, and National Center for Biotechnology Information are among the primary and secondary sources referred to while preparing the Latin America chemiluminescence immunoassay market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Research Methodology

  • 2.1 Coverage
  • 2.2 Secondary Research
  • 2.3 Primary Research

3. Latin America Chemiluminescence Immunoassay (CLIA) Market Landscape

  • 3.1 Market Overview
  • 3.2 PEST Analysis

4. Latin America Chemiluminescence Immunoassay (CLIA) Market - Key Market Dynamics

  • 4.1 Latin America Chemiluminescence Immunoassay Market - Key Market Dynamics
  • 4.2 Market Drivers:
    • 4.2.1 Rising Incidence of Infectious Diseases
    • 4.2.2 Growing Use of Point-of-Care Diagnostics
  • 4.3 Market Restraints
    • 4.3.1 Inadequate Reimbursement
  • 4.4 Market Opportunities
    • 4.4.1 Increasing Focus on R&D
  • 4.5 Future Trends
    • 4.5.1 Technological Advancement
  • 4.1 Impact of Drivers and Restraints:

5. Latin America Chemiluminescence Immunoassay (CLIA) Market Analysis

  • 5.1 Chemiluminescence Immunoassay (CLIA) Market
    • 5.1.1 Overview
    • 5.1.2 Chemiluminescence Immunoassay (CLIA): Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)

6. Latin America Chemiluminescence Immunoassay (CLIA) Market Analysis - by Application

  • 6.1 Oncology
    • 6.1.1 Overview
    • 6.1.2 Oncology: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.2 Fertility
    • 6.2.1 Overview
    • 6.2.2 Fertility: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.3 Endocrinology
    • 6.3.1 Overview
    • 6.3.2 Endocrinology: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.4 Cardiology
    • 6.4.1 Overview
    • 6.4.2 Cardiology: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.5 Infectious Diseases
    • 6.5.1 Overview
    • 6.5.2 Infectious Diseases: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.6 Diabetes
    • 6.6.1 Overview
    • 6.6.2 Diabetes: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.7 Others
    • 6.7.1 Overview
    • 6.7.2 Others: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)

7. Latin America Chemiluminescence Immunoassay (CLIA) Market Analysis - by End User

  • 7.1 Hospitals
    • 7.1.1 Overview
    • 7.1.2 Hospitals: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Blood Banks
    • 7.2.1 Overview
    • 7.2.2 Blood Banks: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Clinical Laboratories
    • 7.3.1 Overview
    • 7.3.2 Clinical Laboratories: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Pharmaceutical & Biotech Companies
    • 7.4.1 Overview
    • 7.4.2 Pharmaceutical & Biotech Companies: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)

8. Latin America Chemiluminescence Immunoassay (CLIA) Market - Regional Analysis

  • 8.1 Overview
  • 8.2 Latin America
    • 8.2.1 Latin America Chemiluminescence Immunoassay (CLIA) Market Overview
    • 8.2.2 Latin America: Latin America Chemiluminescence Immunoassay (CLIA)- Revenue and Forecast to 2031 (US$ Million)
      • 8.2.2.1 Latin America: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast Analysis - by Application
      • 8.2.2.2 Latin America: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast Analysis - by End User
      • 8.2.2.3 Brazil: Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.2.2.3.1 Brazil: Chemiluminescence Immunoassay (CLIA) Market Breakdown, by Application
        • 8.2.2.3.2 Brazil: Chemiluminescence Immunoassay (CLIA) Market Breakdown, by End User
      • 8.2.2.4 Argentina: Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.2.2.4.1 Argentina: Chemiluminescence Immunoassay (CLIA) Market Breakdown, by Application
        • 8.2.2.4.2 Argentina: Chemiluminescence Immunoassay (CLIA) Market Breakdown, by End User
      • 8.2.2.5 Chile: Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.2.2.5.1 Chile: Chemiluminescence Immunoassay (CLIA) Market Breakdown, by Application
        • 8.2.2.5.2 Chile: Chemiluminescence Immunoassay (CLIA) Market Breakdown, by End User
      • 8.2.2.6 Mexico: Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.2.2.6.1 Mexico: Chemiluminescence Immunoassay (CLIA) Market Breakdown, by Application
        • 8.2.2.6.2 Mexico: Chemiluminescence Immunoassay (CLIA) Market Breakdown, by End User
      • 8.2.2.7 Rest of Latin America: Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.2.2.7.1 Rest of Latin America: Chemiluminescence Immunoassay (CLIA) Market Breakdown, by Application
        • 8.2.2.7.2 Rest of Latin America: Chemiluminescence Immunoassay (CLIA) Market Breakdown, by End User

9. Company Profiles

  • 9.1 Sysmex Corp
    • 9.1.1 Key Facts
    • 9.1.2 Business Description
    • 9.1.3 Products and Services
    • 9.1.4 Financial Overview
    • 9.1.5 SWOT Analysis
    • 9.1.6 Key Developments
  • 9.2 Shenzhen Mindray Bio-Medical Electronics Co Ltd
    • 9.2.1 Key Facts
    • 9.2.2 Business Description
    • 9.2.3 Products and Services
    • 9.2.4 Financial Overview
    • 9.2.5 SWOT Analysis
    • 9.2.6 Key Developments
  • 9.3 Bio-Rad Laboratories Inc
    • 9.3.1 Key Facts
    • 9.3.2 Business Description
    • 9.3.3 Products and Services
    • 9.3.4 Financial Overview
    • 9.3.5 SWOT Analysis
    • 9.3.6 Key Developments
  • 9.4 Merck KGaA
    • 9.4.1 Key Facts
    • 9.4.2 Business Description
    • 9.4.3 Products and Services
    • 9.4.4 Financial Overview
    • 9.4.5 SWOT Analysis
    • 9.4.6 Key Developments
  • 9.5 Abbott Laboratories
    • 9.5.1 Key Facts
    • 9.5.2 Business Description
    • 9.5.3 Products and Services
    • 9.5.4 Financial Overview
    • 9.5.5 SWOT Analysis
    • 9.5.6 Key Developments
  • 9.6 Thermo Fisher Scientific Inc.
    • 9.6.1 Key Facts
    • 9.6.2 Business Description
    • 9.6.3 Products and Services
    • 9.6.4 Financial Overview
    • 9.6.5 SWOT Analysis
    • 9.6.6 Key Developments
  • 9.7 Hoffmann-La Roche Ltd
    • 9.7.1 Key Facts
    • 9.7.2 Business Description
    • 9.7.3 Products and Services
    • 9.7.4 Financial Overview
    • 9.7.5 SWOT Analysis
    • 9.7.6 Key Developments
  • 9.8 DiaSorin SpA
    • 9.8.1 Key Facts
    • 9.8.2 Business Description
    • 9.8.3 Products and Services
    • 9.8.4 Financial Overview
    • 9.8.5 SWOT Analysis
    • 9.8.6 Key Developments
  • 9.9 Siemens Healthineers AG
    • 9.9.1 Key Facts
    • 9.9.2 Business Description
    • 9.9.3 Products and Services
    • 9.9.4 Financial Overview
    • 9.9.5 SWOT Analysis
    • 9.9.6 Key Developments
  • 9.10 Getein Biotech Inc.
    • 9.10.1 Key Facts
    • 9.10.2 Business Description
    • 9.10.3 Products and Services
    • 9.10.4 Financial Overview
    • 9.10.5 SWOT Analysis
    • 9.10.6 Key Developments

10. Appendix

  • 10.1 About The Insight Partners
  • 10.2 Glossary of Terms

List Of Tables

  • Table 1. Latin America Chemiluminescence Immunoassay (CLIA) Market Segmentation
  • Table 2. Latin America Chemiluminescence Immunoassay (CLIA) Market- Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 3. Latin America Chemiluminescence Immunoassay (CLIA) Market- Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 4. Latin America: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 5. Latin America: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 6. Brazil: Chemiluminescence Immunoassay (CLIA) Market- Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 7. Brazil: Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 8. Argentina: Chemiluminescence Immunoassay (CLIA) Market- Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 9. Argentina: Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 10. Chile: Chemiluminescence Immunoassay (CLIA) Market- Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 11. Chile: Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 12. Mexico: Chemiluminescence Immunoassay (CLIA) Market- Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 13. Mexico: Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 14. Rest of Latin America: Chemiluminescence Immunoassay (CLIA) Market- Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 15. Rest of Latin America: Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 16. Glossary of Terms, Latin America Chemiluminescence Immunoassay (CLIA) Market

List Of Figures

  • Figure 1. Analysis
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. Chemiluminescence Immunoassay (CLIA): Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 4. Latin America Chemiluminescence Immunoassay (CLIA) Market Share (%) - by Application (2024 and 2031)
  • Figure 5. Oncology: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 6. Fertility: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Endocrinology: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Cardiology: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Infectious Diseases: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Diabetes: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Others: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Latin America Chemiluminescence Immunoassay (CLIA) Market Share (%) - by End User (2024 and 2031)
  • Figure 13. Hospitals: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Blood Banks: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Clinical Laboratories: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Pharmaceutical & Biotech Companies: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Others: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Latin America Chemiluminescence Immunoassay (CLIA) Market Breakdown by Countries, 2023 and 2031 (%)
  • Figure 19. Latin America: Latin America Chemiluminescence Immunoassay (CLIA), by Key Country - Revenue (2023) (USD Million)
  • Figure 20. Latin America: Latin America Chemiluminescence Immunoassay (CLIA)- Revenue and Forecast to 2031(US$ Million)
  • Figure 21. Brazil: Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 22. Argentina: Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 23. Chile: Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 24. Mexico: Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 25. Rest of Latin America: Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031(US$ Million)